University of Virginia researchers are working to outrace two dangerous germs known for quickly developing resistance to new antibiotics – and the scientists’ efforts could help us better combat antibiotic resistance more broadly.
Jury awards Natera $96M+ in blood test patent fight
CareDx said it will fight a $96 million jury verdict in the company’s years-long patent battle with Natera over their rival kidney transplant rejection tests.